Advertisements


Sage Therapeutics started at outperform with $170 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 11th, 2018

Outlook Therapeutics started at outperform with $12 stock price target at Oppenheimer

Oppenheimer initiated coverage of Outlook Therapeutics Inc's .....»»

Category: topSource: marketwatchMay 16th, 2019

Allogene Therapeutics started at outperform with $45 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 3rd, 2019

Trevi Therapeutics started at outperform with $15 stock price target at BMO Research

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 3rd, 2019

Brainsway started at outperform with $17 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 13th, 2019

Tufin Software started at outperform with $35 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 6th, 2019

Tencent started at outperform with $55 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 10th, 2019

Focus Financial started at outperform with $48 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 9th, 2019

Axsome Therapeutics started at outperform with $25 stock price target at SVB Leerink

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 8th, 2019

Aptiv started at outperform with $93 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMar 28th, 2019

Allogene Therapeutics started at outperform with $40 stock price target at Raymond James

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMar 15th, 2019

Magenta Therapeutics started at outperform with $22 stock price target at Raymond James

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMar 15th, 2019

Unum Therapeutics started at outperform with $18 stock price target at Wedbush

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 23rd, 2018

Gemphire Therapeutics started at outperform with $22 stock price target

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 16th, 2018

Wyndham Hotels & Resorts started at outperform with $69 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 4th, 2018

ArQule started at outperform with $7 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 12th, 2018

Alpine Immune Sciences started at outperform with $13 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 29th, 2018

Synlogic started at outperform with $18 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 29th, 2018

Akoustis Technologies started at outperform with $10 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 30th, 2018

MongoDB started at outperform with $80 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 17th, 2018

AxurRx BioPharma started at outperform with $6 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 17th, 2018